115 related articles for article (PubMed ID: 16163043)
1. 3-T proton magnetic resonance spectroscopy of central neurocytoma: 3 case reports and review of the literature.
Chuang MT; Lin WC; Tsai HY; Liu GC; Hu SW; Chiang IC
J Comput Assist Tomogr; 2005; 29(5):683-8. PubMed ID: 16163043
[TBL] [Abstract][Full Text] [Related]
2. Proton MR spectroscopy of central neurocytoma using short and long echo time: new proofs for the existence of glycine and glutamate.
Liu M; Yue Q; Isobe T; Matsumura A; Li J; Yang Z; Quan H; Xing H; Gong Q
Acad Radiol; 2012 Jul; 19(7):779-84. PubMed ID: 22503892
[TBL] [Abstract][Full Text] [Related]
3. Alanine peak in central neurocytomas on proton MR spectroscopy.
Krishnamoorthy T; Radhakrishnan VV; Thomas B; Jeyadevan ER; Menon G; Nair S
Neuroradiology; 2007 Jul; 49(7):551-4. PubMed ID: 17364196
[TBL] [Abstract][Full Text] [Related]
4. Automated MR spectroscopy of intra- and extraventricular neurocytomas.
Ueda F; Suzuki M; Matsui O; Uchiyama N
Magn Reson Med Sci; 2007; 6(2):75-81. PubMed ID: 17690537
[TBL] [Abstract][Full Text] [Related]
5. In vivo proton magnetic resonance spectroscopy of central neurocytomas.
Kim DG; Choe WJ; Chang KH; Song IC; Han MH; Jung HW; Cho BK
Neurosurgery; 2000 Feb; 46(2):329-33; discussion 333-4. PubMed ID: 10690721
[TBL] [Abstract][Full Text] [Related]
6. MR Spectroscopy to Distinguish between Supratentorial Intraventricular Subependymoma and Central Neurocytoma.
Ueda F; Aburano H; Ryu Y; Yoshie Y; Nakada M; Hayashi Y; Matsui O; Gabata T
Magn Reson Med Sci; 2017 Jul; 16(3):223-230. PubMed ID: 27941295
[TBL] [Abstract][Full Text] [Related]
7. Measurement of glycine in a brain and brain tumors by means of 1H MRS.
Bobek-Billewicz B; Hebda A; Stasik-Pres G; Majchrzak K; Zmuda E; Trojanowska A
Folia Neuropathol; 2010; 48(3):190-9. PubMed ID: 20925003
[TBL] [Abstract][Full Text] [Related]
8. MRS characterization of central neurocytomas using glycine.
Shah T; Jayasundar R; Singh VP; Sarkar C
NMR Biomed; 2011 Dec; 24(10):1408-13. PubMed ID: 21465595
[TBL] [Abstract][Full Text] [Related]
9. Proton magnetic resonance spectroscopy of neurocytoma outside the ventricular region--case report and review of the literature.
Möller-Hartmann W; Krings T; Brunn A; Korinth M; Thron A
Neuroradiology; 2002 Mar; 44(3):230-4. PubMed ID: 11942378
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro MR spectroscopic profile of central neurocytomas.
Jayasundar R; Shah T; Vaishya S; Singh VP; Sarkar C
J Magn Reson Imaging; 2003 Feb; 17(2):256-60. PubMed ID: 12541233
[TBL] [Abstract][Full Text] [Related]
11. In vivo proton magnetic resonance spectroscopy of brain tumors.
Fountas KN; Kapsalaki EZ; Gotsis SD; Kapsalakis JZ; Smisson HF; Johnston KW; Robinson JS; Papadakis N
Stereotact Funct Neurosurg; 2000; 74(2):83-94. PubMed ID: 11251398
[TBL] [Abstract][Full Text] [Related]
12. Central neurocytoma: typical magnetic resonance spectroscopy findings and atypical ventricular dissemination.
Yeh IB; Xu M; Ng WH; Ye J; Yang D; Lim CC
Magn Reson Imaging; 2008 Jan; 26(1):59-64. PubMed ID: 17574365
[TBL] [Abstract][Full Text] [Related]
13. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
14. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2.
Zhang K; Li C; Liu Y; Li L; Ma X; Meng X; Feng D
Neuroradiology; 2007 Nov; 49(11):913-9. PubMed ID: 17763847
[TBL] [Abstract][Full Text] [Related]
17. The role of MR spectroscopy in neurooncology.
Kozić D; Ostojić J; Bjelan M; Koprivšek K
Prilozi; 2012; 33(1):425-33. PubMed ID: 23037188
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile.
Chernov MF; Hayashi M; Izawa M; Ono Y; Hori T
Int J Clin Oncol; 2006 Oct; 11(5):375-84. PubMed ID: 17058135
[TBL] [Abstract][Full Text] [Related]
19. (201)Tl-SPECT, (1)H-MRS, and MIB-1 labeling index of central neurocytomas: three case reports.
Kanamori M; Kumabe T; Shimizu H; Yoshimoto T
Acta Neurochir (Wien); 2002 Feb; 144(2):157-63; discussion 163. PubMed ID: 11862516
[TBL] [Abstract][Full Text] [Related]
20. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
Zeng QS; Li CF; Zhang K; Liu H; Kang XS; Zhen JH
J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
